市场调查报告书
商品编码
1567813
2030 年亚太地区分子光谱市场预测 - 区域分析 - 按产品、技术和应用Asia Pacific Molecular Spectroscopy Market Forecast to 2030 - Regional Analysis - by Product, Technology, and Application |
2022年亚太分子光谱市值为8.4903亿美元,预计2030年将达到12.8151亿美元;预计2022年至2030年复合年增长率为5.3%。
核磁共振光谱的使用增加推动亚太地区分子光谱市场
NMR 是一种用于品质控制和研究的分析技术,可透过其分子结构确定样品的纯度。 NMR 是分析化学和综合物质科学以及阐明大分子结构和动力学的强大工具。核磁共振波谱的优点在于它需要较少的样品製备,并且是一种无损方法,可以保存所研究的分子。核磁共振波谱已成为寻找有机化合物结构的领先技术之一,并广泛应用于製药、生物技术和生物製药等各个领域。此外,核磁共振波谱也越来越多地用于生化和生物应用,包括先导化合物检测、代谢物分析、体内磁振造影波谱和磁振造影。近年来,核磁共振已被大量纳入代谢组学。这个快速发展的领域涉及透过研究代谢物来获取有关疾病的资讯。代谢组学传统上专注于研究应用,并且在实验室诊断中非常有用。代谢组学可以提供有关代谢和细胞过程下游产物的有价值的信息,并提供对特定组织和器官状态的深入了解。核磁共振波谱已成功量化各种液体中的代谢物浓度,包括尿液、血浆和血清。核磁共振波谱学取得了新的发展,推动了灵敏度和多功能性方面急需的改进,并扩大了应用数量。将先进的核磁共振诊断技术引入第一线医疗保健产业将可能实现对各种疾病的快速且经济高效的诊断。随着研究和产业需求的不断发展,核磁共振波谱仍处于分析技术的前沿,并推动波谱市场的成长。此外,由于保育研究的不断增加以及政府促进环境研究的有利政策,分子光谱学也得到了显着的推动。分子光谱通常用作调查和环境研究中的分析工具。因此,市场参与者正在探索用于各种环境研究的创新分子光谱方法。预计这种情况将在预测期内持续下去,并为市场提供成长机会。
亚太地区分子光谱市场概况
亚太地区分子光谱市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。预计中国将在 2022 年占据最大的市场份额,而印度预计将在市场中呈现显着的成长速度。这是由于中国的生物製药产业正在经历巨大转变,从以仿製药为中心转变为蓬勃发展的创新中心。此外,推动新药、高端医疗器材和技术的产业化和应用也是中国市场成长的原因。此外,越来越多的市场参与者专注于亚太地区国家的地理扩张和其他策略,以及不断增加的研究中心和政府资助推动了分子光谱市场的成长。
亚太地区分子光谱市场收入及 2030 年预测(百万美元)
亚太地区分子光谱市场区隔
亚太地区分子光谱市场分为产品、技术、应用和国家。
根据产品,亚太分子光谱市场分为仪器和配件。 2022年,仪器仪表领域将占据更大的市场份额。
从技术角度来看,亚太分子光谱市场分为紫外-可见光光谱、红外光谱、核磁共振光谱、拉曼光谱、近红外光谱等。紫外-可见光光谱领域在 2022 年占据最大的市场。
按应用划分,亚太地区分子光谱市场分为学术和研究应用、生物技术应用、製药应用等。 2022 年,学术和研究应用领域占据最大的市场份额。
依国家/地区划分,亚太地区分子光谱市场分为澳洲、中国、印度、日本、韩国和亚太地区其他地区。 2022年,中国在亚太分子光谱市场份额中占据主导地位。
堀场有限公司;赛默飞世尔科技公司;默克公司; Revvity公司; Ostec 仪器;日本电子有限公司;岛津公司;日本分光公司;布鲁克公司;安捷伦科技公司;牛津仪器公司;和 Teledyne Princeton Instruments 是亚太分子光谱市场上的一些领先公司。
The Asia Pacific molecular spectroscopy market was valued at US$ 849.03 million in 2022 and is expected to reach US$ 1,281.51 million by 2030; it is estimated to register a CAGR of 5.3% from 2022 to 2030.
Increasing Use of Nuclear Magnetic Resonance Spectroscopy Boosts Asia Pacific Molecular Spectroscopy Market
NMR is an analytical technique used for quality control and research to determine the purity of a sample with its molecular structure. NMR is a powerful tool in terms of analytical chemistry and consolidated matter science, as well as for elucidating the structure and dynamics of macromolecules. The benefits of NMR spectroscopy are that it requires less sample preparation and is a non-destructive method that preserves the molecules being studied. NMR spectroscopy has become one of the leading techniques for finding out the structure of organic compounds and is widely used in various areas such as pharmaceuticals, biotechnology, and biopharmaceuticals. In addition, NMR spectroscopy is increasingly used in biochemical and biological applications, including hit-to-lead detection, metabolite profiling, in vivo magnetic resonance spectroscopy, and magnetic resonance imaging. In recent years, NMR has been heavily incorporated into metabolomics. This rapidly growing field involves the study of metabolites to gain information about diseases. Metabolomics has traditionally focused on research applications and can prove extremely useful in laboratory diagnostics. Metabolomics can provide valuable information about downstream products of metabolic and cellular processes and provide insights into the state of specific tissues and organs. NMR spectroscopy has successfully quantified metabolite concentrations in various fluids, including urine, plasma, and serum. New developments have been made in NMR spectroscopy, driving much-needed improvements in sensitivity and versatility, and expanding the number of applications. Introducing advanced NMR diagnostic techniques to the frontline healthcare industry will likely enable rapid and cost-effective diagnosis of various diseases. As research and industry needs continue to evolve, NMR spectroscopy remains at the forefront of analytical techniques and drives growth in the spectroscopy market. In addition, molecular spectroscopy has propelled significantly due to increasing research in conservation and favorable government policies to promote environmental studies. Molecular spectroscopy is often used as an analytical tool in surveys and environmental studies. Therefore, market participants are exploring innovative molecular spectroscopy methods for various environmental studies. This is expected to continue during the forecast period and provide growth opportunities for the market.
Asia Pacific Molecular Spectroscopy Market Overview
The Asia Pacific molecular spectroscopy market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China is predicted to hold the largest share of the market in 2022, and India is expected to show a significant growth rate in the market. This is due to China's biopharmaceutical industry undergoing a tremendous shift, evolving from a generic-focused to a thriving innovation hub. Additionally, promoting industrialization and the application of novel drugs, high-end medical devices, and techniques are responsible for the market growth in China. Further, the growing number of market players focusing on countries in Asia Pacific for geographical expansion and other strategies and the rising research centers and government funding fuel the molecular spectroscopy market growth.
Asia Pacific Molecular Spectroscopy Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Molecular Spectroscopy Market Segmentation
The Asia Pacific molecular spectroscopy market is segmented into product, technology, application, and country.
Based on product, the Asia Pacific molecular spectroscopy market is bifurcated into instrument and accessories. The instrument segment held a larger market share in 2022.
In terms of technology, the Asia Pacific molecular spectroscopy market is categorized into UV-Visible spectroscopy, infrared spectroscopy, nuclear magnetic resonance spectroscopy, Raman spectroscopy, Near-infrared spectroscopy, and others. The UV-Visible spectroscopy segment held the largest market share in 2022.
By application, the Asia Pacific molecular spectroscopy market is segmented into academic and research applications, biotechnology applications, pharmaceutical applications, and others. The academic and research applications segment held the largest market share in 2022.
Based on country, the Asia Pacific molecular spectroscopy market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific molecular spectroscopy market share in 2022.
Horiba Ltd; Thermo Fisher Scientific Inc; Merck KGaA; Revvity Inc; Ostec Instruments; JEOL Ltd; Shimadzu Corp; JASCO Corp; Bruker Corp; Agilent Technologies, Inc.; Oxfords Instruments plc; and Teledyne Princeton Instruments are some of the leading companies operating in the Asia Pacific molecular spectroscopy market.